Wu C, Xue L, Wu M, Li S, et al. Non-gene-edited, CD19-targeted, allogeneic CAR-T cell therapy for relapsed or refractory B-cell acute lymphoblastic leukemia: an open-label, single-arm phase 1 study. Bone Marrow Transplant 2026 Jun 4. doi: 10.1038/s41409-026-02929.
PMID: 42237011